Susquehanna International Group’s Precision BioSciences DTIL Stock Holding History

Susquehanna International Group’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-517	Closed	-$48K	–	13095
2022 Q1	$48K	Sell	517 -1,266	-71%	-$172K	﹤0.01%	12329
2021 Q4	$396K	Sell	1,783 -107	-6%	-$29.9K	﹤0.01%	9805
2021 Q3	$654K	Sell	1,890 -1,033	-35%	-$350K	﹤0.01%	8694
2021 Q2	$1.1M	Buy	2,923 +256	+10%	+$76.9K	﹤0.01%	7507
2021 Q1	$828K	Sell	2,667 -1,373	-34%	-$481K	﹤0.01%	8217
2020 Q4	$1.01M	Buy	4,040 +3,663	+972%	+$898K	﹤0.01%	6705
2020 Q3	$70K	Sell	377 -1,613	-81%	-$321K	﹤0.01%	10091
2020 Q2	$497K	Buy	1,990 +30	+2%	+$6.57K	﹤0.01%	7372
2020 Q1	$355K	Buy	1,960 +1,023	+109%	+$268K	﹤0.01%	7651
2019 Q4	$390K	Buy	+937	New	+$294K	﹤0.01%	7477

Other funds holding DTIL

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Susquehanna International Group's DTIL Position: Q1 2026 in Review

Susquehanna International Group reduced its Precision BioSciences (DTIL) stake by 3.2% in Q1 2026, selling an estimated $9.78K and leaving 64,462 shares worth $355K. The position accounts for ﹤0.01% of the portfolio, ranked #10497.

Susquehanna International Group first reported a position in DTIL in Q4 2019 and has held it in 18 quarters since. The position peaked at $1.78M in Q2 2021. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

Susquehanna International Group held 64,462 shares of Precision BioSciences worth $355K as of Q1 2026.
Susquehanna International Group sold 2,119 Precision BioSciences shares in Q1 2026, an estimated $9.78K.
Precision BioSciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10497 holding.
Susquehanna International Group first reported a position in Precision BioSciences in Q4 2019 and has held it in 18 quarters since.
Susquehanna International Group's Precision BioSciences position peaked at $1.78M in Q2 2021.
78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.